Exploring the Potential of Robotic Telesurgery in Remote Settings

Last updated: August 16, 2025
Sponsor: AdventHealth
Overall Status: Active - Recruiting

Phase

N/A

Condition

Prostate Cancer

Prostate Disorders

Prostate Cancer, Early, Recurrent

Treatment

Telesurgery utilizing Microport Medbot Robotic Platform

Clinical Study ID

NCT07130708
2294288
  • Ages 18-90
  • Male

Study Summary

This study involves a type of robotic surgery called telesurgery, where a highly trained surgeon performs the surgical procedure using a secure internet connection to operate on a patient in a different location. Urologists from The goal of this study is to find out how safe and effective telesurgery is when used in real hospitals. The study aims to understand how well Telesurgery works in different settings, what technical challenges might come up (like internet speed or delays), and how it can be used to train new surgeons.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age 18 - 90

  • Male or female

  • Eligible participants for this telesurgery study must have a clearly definedindication for robotic urologic surgery, specifically:

  • Localized Prostate Cancer (ICD-10: C61), appropriate for robotic radicalprostatectomy.

OR

-Benign Prostate diseases appropriate for robotic simple prostatectomy (ICD-10: N40) These diagnoses are confirmed by clinical examination, imaging, and/or pathology prior to surgical planning. Patients with vague or unspecified urologic conditions will be excluded to ensure the safety and appropriateness of the surgical intervention.

  • Primary diagnosis of urinary system disease and prostate disorders (C61 and N40.1)scheduled to undergo treatment with robotic surgery. These patients don't haveaccess to robotic surgery in their routine and the study will give them theopportunity to have advanced technology and the gold-standard treatment with expertsin the field.

  • Willing to participate in the study

  • Mentally capable of comprehending the study protocol

Exclusion

Exclusion Criteria:

  • Patients who, based on multidisciplinary evaluation (surgical, anesthetic, andmedical), are deemed not suitable for robotic surgery due to high perioperativerisk. This includes but is not limited to:

  • Uncontrolled cardiovascular, pulmonary, or metabolic disease.

  • Severe anesthetic risk classified as ASA Class IV or higher.

  • Patients enrolled in another interventional research study that may interfere withsurgical safety or outcomes.

  • Patients unwilling or unable to comply with the perioperative and follow-upschedule.

  • Vulnerable populations are excluded from this study, including:

  • Minors (under 18 years old)

  • Prisoners

  • Cognitively impaired or decisional incapacitated individuals

Study Design

Total Participants: 10
Treatment Group(s): 1
Primary Treatment: Telesurgery utilizing Microport Medbot Robotic Platform
Phase:
Study Start date:
June 14, 2025
Estimated Completion Date:
July 30, 2033

Connect with a study center

  • AdventHealth

    Celebration, Florida 34747
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.